News and Updates
February 16th 2015
iVeena appoints Jerry Simmons as CEO and Director
Mr. Simmons brings more than 30 years of large pharmaceutical and early stage drug development company experience. This experience includes several corporate licensing transactions, participation in s
February 10th 2015
iVeena promotes Michael Burr Vice President, Product development
Mr. Burr has over 7 years of experience in ocular drug delivery and device development. From 2008 to 2009, Mr. Burr was a fellow at the Lassonde Entrepreneur Institute. Beginning in June 2009, Mr. Bur
November 20th 2013
iVeena publishes Proof of Concept studies for Post Surgery Cataract Inflammation products
iVeena has demonstrated safety and efficacy in 42 rabbit eyes in treating post-surgical inflammation and retinal thickening (as measured by optical coherence tomography). iVeena has also demonstrated
Page 9 of 9